$8.03
-0.02-0.25%
At close: -
$8.04
0.009900.12%
After Hours: 4:09 PM EDT
Comments
Loading...
Aurinia Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:AUPH | Benzinga
Aurinia Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Jul 31
EPS Estimate
$0.140
Quarterly Revenue Estimate
$64.27M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$247.29M
Analyze the earnings history of Aurinia Pharmaceuticals using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AUPH | Aurinia Pharmaceuticals | $0.01 | $0.14 | — | — | $57.19M | $64.27M | — | — | 07/31/2025 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.07 | $0.10 | $0.16 | 60.00% | $50.30M | $61.06M | $62.47M | 2.30% | 05/12/2025 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.19 | -$0.02 | $0.01 | 150.00% | $45.09M | $59.94M | $59.87M | -0.12% | 02/27/2025 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.09 | $0.01 | $0.10 | 900.00% | $54.52M | $57.69M | $67.77M | 17.47% | 11/07/2024 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.08 | $0.01 | $0.01 | 0.00% | $41.49M | $55.05M | $57.19M | 3.89% | 08/01/2024 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.18 | -$0.14 | -$0.03 | 78.57% | $34.41M | $47.45M | $50.30M | 6.01% | 05/02/2024 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.18 | -$0.16 | -$0.19 | -18.75% | $28.43M | $44.45M | $45.09M | 1.45% | 02/15/2024 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.06 | -$0.17 | -$0.09 | 47.06% | $55.78M | $38.50M | $54.52M | 41.60% | 11/02/2023 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.25 | -$0.20 | -$0.08 | 60.00% | $28.19M | $36.37M | $41.49M | 14.09% | 08/03/2023 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.27 | -$0.22 | -$0.18 | 18.18% | $21.63M | $27.87M | $34.41M | 23.46% | 05/04/2023 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.25 | -$0.27 | -$0.18 | 33.33% | $23.40M | $27.78M | $28.43M | 2.36% | 02/28/2023 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.39 | -$0.17 | -$0.06 | 64.71% | $14.67M | $36.18M | $55.78M | 54.17% | 11/03/2022 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.37 | -$0.22 | -$0.25 | -13.64% | $6.62M | $27.14M | $28.19M | 3.87% | 08/04/2022 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.40 | -$0.27 | -$0.27 | 0.00% | $914.00K | $19.76M | $21.63M | 9.44% | 05/10/2022 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.06 | — | -$0.25 | — | $50.03M | — | $23.40M | — | 02/28/2022 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.28 | -$0.33 | -$0.39 | -18.18% | $29.00K | $13.88M | $14.67M | 5.67% | 11/03/2021 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.26 | -$0.14 | -$0.37 | -164.29% | $29.00K | $40.00K | $6.62M | 16450.00% | 08/05/2021 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.23 | -$0.14 | -$0.40 | -185.71% | $30.00K | $40.00K | $914.00K | 2185.00% | 05/06/2021 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.29 | -$0.14 | -$0.05 | 64.29% | $29.00K | $40.00K | $50.03M | 124975.00% | 02/24/2021 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.21 | -$0.15 | -$0.28 | -86.67% | $230.00K | $50.00K | $29.00K | -42.00% | 11/10/2020 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.17 | -$0.14 | -$0.26 | -85.71% | $29.00K | $40.00K | $29.00K | -27.50% | 08/11/2020 | Get Alert |
Aurinia Pharmaceuticals (AUPH) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-12 | $0.16 | $0.10 | 60.0 % |
| Q4 | 2025-02-27 | $0.01 | $-0.02 | 150.0 % |
| Q3 | 2024-11-07 | $0.10 | $0.01 | 900.0 % |
| Q2 | 2024-08-01 | $0.01 | $0.01 | 0.00 % |
Aurinia Pharmaceuticals (AUPH) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-12 | $62.47M | $61.06M | 2.30 % |
| Q4 | 2025-02-27 | $59.87M | $59.94M | -0.12 % |
| Q3 | 2024-11-07 | $67.77M | $57.69M | 17.5 % |
| Q2 | 2024-08-01 | $57.19M | $55.05M | 3.89 % |
FAQ
When is Aurinia Pharmaceuticals (NASDAQ:AUPH) reporting earnings?
Aurinia Pharmaceuticals (AUPH) is scheduled to report earnings on July 31, 2025. The last reported earnings were for reported on May 12, 2025 for Q1.
What were the latest earnings per share (EPS) for Aurinia Pharmaceuticals (NASDAQ:AUPH)?
The Actual EPS was $0.16, which beat the estimate of $0.10.
What were Aurinia Pharmaceuticals’s (NASDAQ:AUPH) revenues?
The Actual Revenue was $62.5M, which beat the estimate of $61.1M.
Browse earnings estimates, EPS, and revenue on all stocks.
